These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4976302)

  • 1. [Interruption of pregnancy in hemolytic disease of newborn? Basis for the calculation of homozygosis and heterozygosis in the most important D-positive RH-types].
    Dahr P; Merkl H
    Med Welt; 1967 Sep; 37():2174-6. PubMed ID: 4976302
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygosis, heterozygosis and the gene incidence in the blood factors Rh: C, c, D, E, e in the population of Poland.
    Marcinkowski T
    Pol Med J; 1968; 7(1):78-83. PubMed ID: 4967785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic examination in cases of death of the fetus due to hemolytic disease of the newborns].
    Kulich V; Pribilová A; Havránek E
    Cesk Gynekol; 1971 Apr; 36(3):136-9. PubMed ID: 4996773
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of fatal hemolytic disease of the newborn associated with-D-/-D-phenotype.
    Han KS; Kim HC; Han KS; Shim WS
    Am J Perinatol; 1997 Sep; 14(8):495-7. PubMed ID: 9376014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoGam--current status.
    Russell KP
    Calif Med; 1970 Dec; 113(6):44-5. PubMed ID: 4098761
    [No Abstract]   [Full Text] [Related]  

  • 6. [In favor of a national program of prevention of Rh-hemolytic disease of the newborn].
    Dambrosio F
    Ann Ostet Ginecol Med Perinat; 1972 Feb; 93(2):114-7. PubMed ID: 4630080
    [No Abstract]   [Full Text] [Related]  

  • 7. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract]   [Full Text] [Related]  

  • 9. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemolytic disease of the newborn from the viewpoint of the obstetrician].
    Oehlert G
    Landarzt; 1966 Nov; 42(32):1432-5. PubMed ID: 4962787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present attitudes toward Rhesus iso-immunizations].
    Wilson E
    Rev Med Suisse Romande; 1971 Dec; 91(12):939-62. PubMed ID: 5004027
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn].
    Holtorff J; Brey J; Nitzsche M
    Zentralbl Gynakol; 1969 May; 91(20):629-47. PubMed ID: 4984542
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.
    Aref K; Boctor FN; Pande S; Uehlinger J; Manning F; Eglowstein M; Mallozzi A; Bebbington M; Weinberg G; Rosen O; Raab C; Brion LP
    J Perinatol; 2002 Dec; 22(8):667-8. PubMed ID: 12478452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z
    Wiad Lek; 1971 Apr; 24(8):755-60. PubMed ID: 4996047
    [No Abstract]   [Full Text] [Related]  

  • 19. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Late results of using plasmapheresis. Prevention of hemolytic disease of the fetus and newborn infant in Rh-compromised pregnancy].
    Timoshenko LV; Timoshenko LI; Minchenko ZhN
    Akush Ginekol (Sofiia); 1986; 25(5):1-8. PubMed ID: 3101532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.